Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Ozempic and other semaglutide medications have skyrocketed in popularity as weight-loss aids, with prescriptions surging by ...

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Novo's shares have been pressured since last year, when the company also suffered a setback after its experimental drug CagriSema showed lower-than-expected weight loss. In December, Lilly said ...

Studies have shown that individuals using semaglutide can achieve an average weight loss of 15-20% when combined with a healthy diet and regular exercise. This remarkable efficacy sets GetSimpli ...

Wegovy and Ozempic have become household names, but how easy are they to get if you don't meet the medical criteria? Sky's Lucy Marley went to find out.

Guidance for diabetes drug Mounjaro is $3.5 billion, while weight loss drug Zepbound is expected to bring in $1.9 billion for the quarter. In the latest weekly prescription tracking from JPMorgan, ...

Applied Digital Posts Smaller-Than-Expected Loss on Demand for Cloud Services (Reuters) - Data center operator Applied Digital on Tuesday posted a smaller-than-expected loss for the second quarter ...